MS_Print Design_Latin America Insight English
2025-05-06 02:29
更多资料加入知识星球:水木调研纪要 关注公众号:水木纪要 M Latin America Insight 更多一手调研纪要和海外投行研报数据加V:shuinu9870 更多一手调研纪要和海外投行研报数据加V:shuinu9870 更多一手调研纪要和海外投行研报数据加V:shuinu9870 更多一手调研纪要和海外投行研报数据加V:shuinu9870 更多一手调研纪要和海外投行研报数据加V:shuinu9870 更多一手调研纪要和海外投行研报数据加V:shuinu9870 更多一手调研纪要和海外投行研报数据加V:shuinu9870 更多一手调研纪要和海外投行研报数据加V:shuinu9870 更多一手调研纪要和海外投行研报数据加V:shuinu9870 Morgan Stanley does and seeks to do business with companies covered in Morgan Stanley Research. As a result, investors should be aware that the firm may have a conflict of interest ...
COSCO Shipping Energy (1138.HK)_ 1Q25 results missed on a lower freight rate with cost increase; restocking remains the market focus
2025-05-06 02:29
30 April 2025 | 11:37AM HKT 更多资料加入知识星球:水木调研纪要 关注公众号:水木纪要 COSCO Shipping Energy (1138.HK) 1Q25 results missed on a lower freight rate with cost increase; restocking remains the market focus COSCO Shipping Energy's share prices (A/H) have retreated by 10%/3% YTD (vs. +11%/-4% for HSCEI/CSI 300), likely reflecting the missed freight rate and the implied potential dilution of 17% (see calculation below) under the terms of the private placement. Going forward, we believe the market focus will be the VLCC-TCE (Ch ...
Container Shipping_ Global Trade Update
2025-05-06 02:29
更多资料加入知识星球:水木调研纪要 关注公众号:水木纪要 Global | Shipping Equity Research April 28, 2025 Container Shipping: Global Trade Update We are introducing a collaborative report on the container industry and the ocean carriers covered by our analysts based in the US, Japan and China. We assess performance, market strategies and outlooks for the top players in the industry including Maersk, COSCO, MOL and others. Our global coverage provides an overview of container shipping trends, and we provide company- specific updates on ...
BYD Co. (.SZ_1211.HK)_ 1Q25 Earnings Review_ Resilience amid macro uncertainty & ongoing competition; Buy
2025-05-06 02:28
更多资料加入知识星球:水木调研纪要 关注公众号:水木纪要 28 April 2025 | 4:57PM CST BYD Co. (002594.SZ/1211.HK) 1Q25 Earnings Review: Resilience amid macro uncertainty & ongoing competition; Buy BYD reported in-line 1Q25 result with net profit of Rmb9.2bn, near mid-point of pre-announcement range of Rmb8.5bn-Rmb10bn (First Take). Looking ahead, we see BYD as one of the most resilient auto OEMs amid macro uncertainty and ongoing competition. (1) Volume: we believe BYD is capable of navigating the uncertain macro economy and competition ...
Hong Kong Exchanges (0388.HK)_ 1Q25 First Take_ in-line; Buy
2025-05-06 02:28
更多资料加入知识星球:水木调研纪要 关注公众号:水木纪要 30 April 2025 | 12:55PM HKT Hong Kong Exchanges (0388.HK): 1Q25 First Take: in-line; Buy HKEX reported 1Q25 EPS of HK$3.23, up 38% yoy, 2% higher vs GSe. Revenue was modestly ahead and costs slightly below GSe. EBITDA was 2% higher, and eff. tax rate was 16%, in-line with GSe. And hence, NPAT was 2% above GSe. That said, profit excluding investment income was 6% below GSe. However, excluding the HK$90mn FCA payment, the miss was 3% on profit excluding II. We would expect a muted ...
Gongniu Group Co Ltd_ Risk Reward Update
2025-05-06 02:28
更多资料加入知识星球:水木调研纪要 关注公众号:水木纪要 April 29, 2025 12:20 AM GMT Gongniu Group Co Ltd | Asia Pacific Risk Reward Update What's Changed Gongniu Group Co Ltd (603195.SS) From To Price Target Rmb103.45 Rmb90.00 Bull Case Rmb155.86 Rmb135.60 Base Case Rmb103.45 Rmb90.00 Bear Case Rmb35.86 Rmb31.20 Updated Components EPS Investment Thesis Bull Base Bear Scenarios 更多一手调研纪要和海外投行研报数据加V:shuinu9870 更多一手调研纪要和海外投行研报数据加V:shuinu9870 更多一手调研纪要和海外投行研报数据加V:shuinu9870 更多一手调研纪要和海外投行研报数据加V:shuinu9870 更多一手调研纪要和海外投行研报数据加V:shuinu9870 更多一手 ...
Fosun Pharmaceutical_ 1Q25 Behind; Innovative Transition Ongoing
2025-05-06 02:28
更多资料加入知识星球:水木调研纪要 关注公众号:水木纪要 M Update 1Q25 Behind; Innovative Transition Ongoing Reaction to earnings April 30, 2025 04:07 AM GMT Fosun Pharmaceutical | Asia Pacific Morgan Stanley Asia Limited+ Yanru Tao Equity Analyst Yanru.Tao@morganstanley.com +852 3963-1041 Alexis Yan, CFA Equity Analyst Alexis.Yan@morganstanley.com +852 2239-7953 Impact to our thesis Financial results versus consensus Direction of next 12-month Unchanged Meaningful shortfall Meaningful revision lower consensus EPS Key Takeaways 1Q25 R ...
LONGi Green Energy Technology Co_ 1Q25 GPM declines; first sign of BC module scaling
2025-05-06 02:28
更多资料加入知识星球:水木调研纪要 关注公众号:水木纪要 April 30, 2025 01:20 AM GMT LONGi Green Energy Technology Co | Asia Pacific M Update 1Q25 GPM declines; first sign of BC module scaling Reaction to earnings Unchanged In-line Largely unchanged Impact to our thesis Financial results versus consensus Direction of next 12-month Source: Company data, Morgan Stanley Research LONGi reported a 2024 net loss of Rmb8.6bn, vs a 2023 net profit of Rmb10.8bn. Inventory impairments were Rmb6.1bn, vs Rmb5.2bn in 2023. GPM narrowed by 11.1ppts ...
Global Markets Analyst_ UK Real Rates — Backcast To The Future
2025-05-06 02:28
更多资料加入知识星球:水木调研纪要 关注公众号:水木纪要 Global Markets Analyst UK Real Rates — Backcast To The Future UK Real Rates — Backcast To The Future UK real rates, measured by inflation-indexed Gilt yields, are at or near decadal highs following a significant increase through 2021-2023. The UK was one of the earliest adopters of inflation-indexed bonds, and so already has a long timeseries of ex ante (traded) real rates, dating back to the early 1980s. We use this time series to backcast real yields, drawing on an approach by ...
China Healthcare_Takeaways on tariffs from clients and expert calls
2025-05-06 02:27
更多资料加入知识星球:水木调研纪要 关注公众号:水木纪要 China Healthcare Equities Takeaways on tariffs from clients and expert calls China We held joint marketing with HSBC global healthcare analysts Rajesh Kumar and Damayanti Kerai, as well an expert call, discussing the US tariff impact on China's and the global pharmaceutical supply chain. Below are our key takeaways: Tariff impact from highest to lowest: medical consumables, devices, drugs. The exact timeline and scope of tariffs remains unclear, but we expect tariffs on US pharm ...